The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical trial in China on Wednesday, as an adult received a shot at a clinical ...

Regulatory authorities in the US are investigating a possible link between the new Pfizer/BioNTech bivalent COVID-19 booster vaccine and strokes in people aged 65 or over, but still recommend the ...

The bivalent RSV prefusion F vaccine (Abrysvo) demonstrated 90% vaccine effectiveness (VE) in high-risk adults against ...

Since their introduction last year, researchers have been monitoring the real-world impact of the new respiratory syncytial ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the fall and winter seasons. Here we answer common questions about the latest ...

Obstetrical and Gynaecological Society of Bangladesh today said the human papillomavirus (HPV) vaccine is safe and effective ...

Researchers from Phoenixlab, The Scripps Research Institute and affiliated organizations presented the discovery of a novel bivalent protease-activated receptor PAR1- and PAR3-derived peptide, named ...

Childhood vaccinations are crucial for protecting children from deadly infections. Vaccines work by stimulating the immune ...

O'Rourke and colleagues have been evaluating a bivalent CAR T-cell therapy for recurrent glioblastoma, a frequently treatment ...

Amid current economic uncertainties and market volatility, investing in defensive stocks appears as an ideal strategy for ...

With the rise of chronic diseases, technological advances and innovative drug pipelines are driving significant growth in the ...